Neutrophil-Lymphocyte Ratio Predicts Survival In Platinum-Resistant Ovarian Cancer Patients Treated With Olaparib And Pegylated Liposomal Doxorubicin (Pld): Stratified Analysis From The Phase Ii Clinical Trial Rolando, Geico-1601
ANNALS OF ONCOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要